Home Portfolio Strategy Team News Contact Actively building life science companies 5AM Ventures is a leading venture capital firm focused on building next-generation life science companies capable of delivering outstanding returns to our investors. Meet Our Team Scroll to experience 5AM Ventures Supporting companies that are working to solve important healthcare needs via cutting-edge breakthroughs in medicine and science. Pear Therapeutics Receives FDA Breakthrough Device Designation for Prescription Digital Therapeutics Candidate to Treat Alcohol Use Disorder 1 2 3 4 5 See More News Pushing the healthcare industry forward $ 0 B UNDER MANAGEMENT We’re a life science venture capital firm founded in 2002 and currently investing $350M from 5AM Ventures VI and $147M from 5AM Opportunities I. 0 PORTFOLIO COMPANIES Our focus is biopharmaceuticals, drug delivery technologies and life science instruments. 0 ONGOING CLINICAL TRIALS Historically our portfolio companies have had over 80,000 patients enrolled across 8,000 test sites in clinical trials. Our Strategy © 2021 5AM Venture Management LLC Investor Login Contact Us Terms of Use Privacy Policy

Home Portfolio Strategy Team News Contact Meet our team 5AM’s investment professionals possess strong scientific, medical, operational, legal and financial expertise. Our complementary backgrounds provide us with a unique edge to find and shape life science portfolio companies. ALL LOCATIONS BOSTON SAN FRANCISCO ALL DEPARTMENTS 5AM INVESTMENT TEAM ADVISORS FINANCE AND OPERATIONS Kush M Parmar, MD, PhD MANAGING PARTNER Andy J. Schwab MANAGING PARTNER David Allison, PhD PARTNER Jamil M. Beg PARTNER Mira Chaurushiya, PhD PARTNER Brian Daniels, MD PARTNER Rebecca Lucia, CFA PARTNER, CHIEF FINANCIAL OFFICER / CHIEF OPERATING OFFICER Deborah Palestrant, PhD PARTNER, HEAD OF 4:59 Jessica Alfano, Esq. CORPORATE COUNSEL, 4:59 INITIATIVE Kamila Bajerski FUND ACCOUNTING MANAGER Galya Blachman, PhD, Esq GENERAL COUNSEL / CHIEF COMPLIANCE OFFICER Jacquelyn Brough, CPA CONTROLLER John D. Diekman, PhD FOUNDING PARTNER Britt Inga Emerson INVESTOR RELATIONS MANAGER Max Farina, MD ASSOCIATE Mason Freeman, MD VENTURE PARTNER Mark A. Gallop, PhD VENTURE ADVISOR Russ Henspeter FUND ACCOUNTING MANAGER Michelle Ho, PhD ASSOCIATE Peter S. Kim, PhD VENTURE ADVISOR Michael P. Klein, MD PRINCIPAL Jennifer Kozub OPERATIONS COORDINATOR AND EXECUTIVE ASSISTANT Pengpeng Li, PhD ASSOCIATE Denise Lyle VICE PRESIDENT, HUMAN RESOURCES Vamsi Mootha, MD VENTURE ADVISOR Henna Morani OFFICE COORDINATOR AND ADMINISTRATIVE ASSISTANT Kori Rahaim VICE PRESIDENT, HEAD OF PEOPLE, 4:59 INITIATIVE Scott M. Rocklage, PhD FOUNDING PARTNER Jason Ruth, PhD PRINCIPAL Mansi Shinde, PhD OPERATING ASSOCIATE, 4:59 INITIATIVE Bryan Song SENIOR ACCOUNTING MANAGER Paula Soteropoulos STRATEGIC ADVISOR Katie Bodner Spielberg, PhD ANALYST Rathnam Venkat ANALYST Joseph J. Victor VENTURE ADVISOR Jenny Wang, CPA DIRECTOR, TAX Mostafa Wassel, J.D. PARALEGAL II Jonathan Weissman, PhD VENTURE ADVISOR James W. Young, PhD VENTURE PARTNER EMERITUS Lindsay Ziegler COMPLIANCE MANAGER © 2021 5AM Venture Management LLC Investor Login Contact Us Terms of Use Privacy Policy